---

---

published : This year    entities : Teva pharmaceutical industries ltd   

save search

---

Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
Published: 2024-04-19 (Crawled : 10:00) - globenewswire.com
ALVO | $13.23 2.64% 2.57% 1.7M |

n/a

| -1.32% | O: 4.19% H: 0.0% C: 0.0%
KMDA | $5.05 -0.98% -0.99% 27K |

Health Technology

| -0.1% | O: 1.76% H: 0.0% C: 0.0%
humira biosimilar approved for agreement

---

Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Published: 2024-04-16 (Crawled : 21:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -0.08% | O: -0.04% H: 0.28% C: -0.16%
stelara fda biosimilar approval teva

---

Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published: 2024-04-16 (Crawled : 14:00) - prnewswire.com
VTRS | $11.25 1.17% 1.16% 4.7M |

Health Technology

| -1.77% | O: -0.53% H: 0.0% C: -1.24%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -1.19% | O: -1.46% H: 0.0% C: 0.0%
PHG | $19.98 0.0% 540K |

Health Technology

| -2.52% | O: -1.21% H: 0.0% C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -2.22% | O: -1.19% H: 0.52% C: -0.17%
VRNA | $15.82 -1.74% -1.83% 640K |

Health Technology

| 1.9% | O: 1.65% H: 2.43% C: 0.87%
reach treatment research market

---

Teva’s New Real-World Evidence Presented at the 2024 AAN Annual Meeting Confirms Effectiveness and Patient Satisfaction for HD Chorea with the 4-week Titration Kit for AUSTEDO® (deutetrabenazine) Tablets
Published: 2024-04-16 (Crawled : 13:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M |

Health Technology

| -0.38% | O: 0.23% H: 0.23% C: -1.28%
austedo for meeting

---

Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China
Published: 2024-04-11 (Crawled : 23:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M |

Health Technology

| -4.84% | O: -1.01% H: 2.04% C: 1.17%
ajovy for teva trial migraine china results

---

Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published: 2024-04-10 (Crawled : 09:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K |

Health Technology

| -10.96% | O: -100.0% H: NaN% C: Infinity%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -1.65% | O: -0.01% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -2.16% | O: -1.67% H: 0.0% C: 0.0%
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -10.79% | O: -0.29% H: 0.0% C: -1.97%
VTRS | $11.25 1.17% 1.16% 4.7M |

Health Technology

| -5.12% | O: -0.6% H: 1.03% C: 0.52%
TMO | News | $544.78 0.6% 0.0% 1.7M |

Health Technology

| -9.54% | O: -2.01% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -2.71% | O: -1.16% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -4.25% | O: -0.32% H: 0.0% C: 0.0%
JAZZ | $109.96 0.63% 0.63% 760K |

Health Technology

| -7.38% | O: -1.71% H: 0.57% C: 0.37%
disorders system set market

---

Teva to Host Conference Call to Discuss First Quarter 2024 Financial Results at 8 a.m. ET on May 8, 2024
Published: 2024-04-09 (Crawled : 23:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M |

Health Technology

| -7.18% | O: -0.7% H: 0.07% C: -0.92%
first conference teva financial results

---

Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 0.01% | O: 2.24% H: 0.0% C: -0.8%
AZNCF | $138.24 -4.19% 800 |

Health Technology

| 1.57% | O: -3.43% H: 6.21% C: 6.21%
VTRS | $11.25 1.17% 1.16% 4.7M |

Health Technology

| -5.76% | O: -0.25% H: 1.1% C: -0.17%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -2.83% | O: -0.05% H: 0.43% C: -0.27%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -5.88% | O: -0.08% H: 0.04% C: -0.35%
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| -16.04% | O: 0.38% H: 0.0% C: -7.27%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| -1.64% | O: 0.77% H: 1.63% C: 0.35%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -3.02% | O: 0.84% H: 0.0% C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 1.21% | O: 0.18% H: 0.3% C: 0.19%
eczema dermatitis set therapeutics market

---

Teva and mAbxience Announce Strategic Global Licensing Agreement for Oncology Biosimilar Candidate
Published: 2024-04-04 (Crawled : 00:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M |

Health Technology

| -6.66% | O: -0.42% H: 0.0% C: 0.0%
candidate biosimilar global for teva agreement

---

Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024
Published: 2024-04-03 (Crawled : 11:00) - globenewswire.com
ALVO | $13.23 2.64% 2.57% 1.7M |

n/a

| 11.67% | O: 2.98% H: 0.17% C: -0.43%
KMDA | $5.05 -0.98% -0.99% 27K |

Health Technology

| -8.36% | O: -0.18% H: 2.16% C: 0.9%
audio

---

Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-03-27 (Crawled : 22:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -4.72% | O: 0.99% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -7.02% | O: -1.17% H: 0.0% C: -0.89%
AZNCF | $138.24 -4.19% 800 |

Health Technology

| 0.45% | O: 0.89% H: 0.78% C: 0.78%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -2.13% | O: -100.0% H: NaN% C: Infinity%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -2.92% | O: 0.52% H: 0.0% C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -7.89% | O: 0.02% H: 0.51% C: -0.3%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -9.3% | O: 0.26% H: 2.03% C: 1.57%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| -8.42% | O: 0.36% H: 0.72% C: 0.61%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -5.06% | O: 1.04% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -8.47% | O: -0.96% H: 0.0% C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 0.01% | O: -0.12% H: 0.25% C: -0.63%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| -7.46% | O: 0.54% H: 0.0% C: 0.0%
abbvie set canada key market

---

Alvotech Announces Increase in Number of Own Shares
Published: 2024-03-22 (Crawled : 20:00) - globenewswire.com
TEVJF | $12.37 -24.22% 380 |

Health Technology

| Email alert Add to watchlist
KMDA | $5.05 -0.98% -0.99% 27K |

Health Technology

| Email alert Add to watchlist
ALVO | $13.23 2.64% 2.57% 1.7M |

n/a

| Email alert Add to watchlist

---

Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
Published: 2024-03-20 (Crawled : 20:00) - globenewswire.com
ALVO | $13.23 2.64% 2.57% 1.7M |

n/a

| -16.41% | O: -1.58% H: 1.87% C: 0.53%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -6.83% | O: -0.03% H: 0.0% C: 0.0%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| -7.32% | O: -0.89% H: 0.0% C: 0.0%
KMDA | $5.05 -0.98% -0.99% 27K |

Health Technology

| -13.2% | O: 0.68% H: 0.0% C: -1.86%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| -2.97% | O: 0.58% H: 1.2% C: 0.84%
business year update financial results

---

Global Angina Pectoris Drugs Market Set for Growth Amid Advancements in Healthcare Infrastructure
Published: 2024-03-11 (Crawled : 23:00) - prnewswire.com
AZNCF | $138.24 -4.19% 800 |

Health Technology

| 1.45% | O: 2.01% H: 0.0% C: -2.01%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -9.19% | O: 1.12% H: 0.0% C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -7.74% | O: 0.02% H: 0.79% C: 0.79%
LLY | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 2.23% | O: 0.9% H: 2.03% C: 1.89%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| -8.02% | O: 1.04% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -5.84% | O: 0.01% H: 0.0% C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 0.88% | O: -0.19% H: 0.22% C: -0.21%
global set growth market

---

Global Fibrate Drugs Market Report 2024: A $5.14 Billion Market by 2034, Rising from S2.95 Billion in 2023
Published: 2024-03-11 (Crawled : 17:00) - prnewswire.com
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -11.91% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -5.31% | O: 0.57% H: 0.0% C: 0.0%
report global market

---

Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ET
Published: 2024-03-05 (Crawled : 21:00) - globenewswire.com
ALVO | $13.23 2.64% 2.57% 1.7M |

n/a

| -21.23% | O: -0.99% H: 0.75% C: -0.13%
KMDA | $5.05 -0.98% -0.99% 27K |

Health Technology

| -20.02% | O: -6.12% H: 1.67% C: 1.17%
year financial results

---

Alvotech Appoints Interim Chief Quality Officer
Published: 2024-02-29 (Crawled : 21:00) - globenewswire.com
ALVO | $13.23 2.64% 2.57% 1.7M |

n/a

| -17.28% | O: -0.58% H: 3.04% C: 3.01%
KMDA | $5.05 -0.98% -0.99% 27K |

Health Technology

| -19.13% | O: -1.27% H: 2.97% C: 2.41%

---

Global Dermatological Drugs Market Set to Surpass US$30 Billion with Advanced Nanotechnology and Aging Population Fostering Growth
Published: 2024-02-28 (Crawled : 11:00) - prnewswire.com
ROIV | $10.46 0.97% 0.96% 4.7M |

Manufacturing

| -11.53% | O: -0.76% H: 0.51% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -9.76% | O: 0.05% H: 0.06% C: -0.95%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -9.41% | O: 0.67% H: 0.0% C: 0.0%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| -7.61% | O: 0.6% H: 0.02% C: -1.03%
global set dermatological advanced growth market

---

Neuroblastoma Drugs Market to Reach $1.3 Billion, Globally, by 2032 at 6.2% CAGR: Allied Market Research
Published: 2024-02-26 (Crawled : 15:00) - prnewswire.com
AZNCF | $138.24 -4.19% 800 |

Health Technology

| 4.77% | O: 3.06% H: 0.0% C: -2.34%
LLY | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| -2.44% | O: 0.23% H: 1.16% C: 0.08%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -6.5% | O: -0.19% H: 0.23% C: -2.02%
UTHR | $237.99 0.45% 0.45% 400K |

Health Technology

| 3.65% | O: -0.48% H: 1.17% C: -1.04%
AZN | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 3.7% | O: 0.38% H: 0.44% C: -0.23%
reach research market

---

Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purchase price of USD 16.41 (ISK 2,250) per Share
Published: 2024-02-26 (Crawled : 10:00) - globenewswire.com
ALVO | $13.23 2.64% 2.57% 1.7M |

n/a

| -20.59% | O: 11.35% H: 0.84% C: -3.25%
KMDA | $5.05 -0.98% -0.99% 27K |

Health Technology

| -17.15% | O: 0.0% H: 1.6% C: -0.49%
million

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | News | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---